Publication:
Trigeminal nerve stimulation: a recently approved treatment approach in attention deficit hyperactivity disorder

Simple item page
dc.contributor.coauthorÇöpür, Mazlum
dc.contributor.departmentN/A
dc.contributor.kuauthorÇöpür, Sidar
dc.contributor.kuprofileResearcher
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid368625
dc.date.accessioned2024-11-09T23:50:54Z
dc.date.issued2021
dc.description.abstractAttention-deficit hyperactivity disorder (ADHD) with its high prevalence is a growing area of concern and research, whereas exact underlying pathophysiology remains unknown. Behavioral therapy and multiple medications include methylphenidate, atomoxetine, and amphetamines while trigeminal nerve stimulator (TNS) is the first medical device in ADHD with FDA approval. The aim of this article is to evaluate the latest studies in this field.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.issue1
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.volume57
dc.identifier.doi10.1186/s41983-021-00353-w
dc.identifier.issn1687-8329
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-85111282525
dc.identifier.urihttp://dx.doi.org/10.1186/s41983-021-00353-w
dc.identifier.urihttps://hdl.handle.net/20.500.14288/14621
dc.identifier.wos678750200002
dc.keywordsAttention-deficit hyperactivity disorder
dc.keywordsTreatment
dc.keywordsTrigeminal nerve
dc.languageEnglish
dc.publisherSpringer
dc.sourceEgyptian Journal of Neurology Psychiatry and Neurosurgery
dc.subjectNeurosciences
dc.titleTrigeminal nerve stimulation: a recently approved treatment approach in attention deficit hyperactivity disorder
dc.typeLetter
dspace.entity.typePublication
local.contributor.authorid0000-0003-0190-2746
local.contributor.kuauthorÇöpür, Sidar

Files

Collections

Publications without Fulltext